Dr. Elena Deliu, PharmD, PhD

Dr. Elena Deliu, PharmD, PhD, is a neuroscientist and pharmacologist specializing in clinical operations, medical affairs, and translational neurobiology. She is currently Head of Clinical Operations at P&F Products & Features GmbH (Vienna), following her tenure as Head of Medical and Scientific Affairs at Brainhero. Across industry and academia, she has led global clinical projects, site operations, regulatory alignment, and cross‑functional delivery, with a track record of securing research funding and guiding complex programs from concept to execution.

Previously, Dr. Deliu served as a Postdoctoral Researcher in the Novarino group at IST Austria and as a Senior Scientist at the University of Vienna, advancing research in neuropharmacology, signal transduction, electrophysiology, and neurodevelopmental disorders. She has authored 26 peer‑reviewed publications with ~1,487 citations, including contributions to Cell on SLC7A5 and autism and Nature Neuroscience on SETD5 and cognition, and she mentors researchers beyond academia (EURAXESS REBECA). She holds a PhD in Pharmacology (Temple University) and a BPharm (Carol Davila University), and maintains certifications in clinical trial operations and analysis. Her current focus includes pivotal cardiovascular device trials and patient‑centric data ecosystems, exemplified by recent work presented to rare disease communities.